cdmo.directory
← Compare landing

ElevateBio vs Hillgene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/elevate/hillgene

CategoryElevateBioHillgene
Listed sitecdmocdmo
SummaryAdvanced therapies CDMO providing discovery, process development, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA, and gene editing programs from preclinical through commercial scale.Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services
  • Cell-Line Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • mRNA Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Vaccine Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
Modalities
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • Cell Therapy
  • mRNA
  • Gene Therapy
Indications
  • Rare Disease
  • Oncology
  • Oncology
  • Immunology
Locations
  • Corporate Headquarters and BaseCamp Waltham, Waltham, MA, USA
  • BaseCamp Pittsburgh, Pittsburgh, PA, USA
  • Gene Editing and Research & Development Site, Durham, NC, USA
  • Process Development Labs and Corporate Offices, Waltham, MA, USA
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
Certifications
  • ICMC · Identifier: ICMC™ Certified for Clinical and Commercial Cell and Gene Therapy Manufacturing Capabilities
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.